Skip to main content
Start of content

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at

Previous day publication Next day publication

Minutes of Proceedings

43rd Parliament, 2nd Session
Meeting 41
Friday, June 4, 2021, 1:16 p.m. to 4:12 p.m.
Ron McKinnon, Chair (Liberal)

Library of Parliament
• Sonya Norris, Analyst
• Tu-Quynh Trinh, Analyst
As an individual
• Steven Morgan, Professor, School of Population and Public Health, University of British Columbia
• Anie Perrault, Chief Executive Officer
• Paul Lévesque, President and Chief Executive Officer, Theratechnologies Inc.
Breast Cancer Action Quebec
• Jennifer Beeman, Executive Director
• Sharon Batt, Co-Founder, Adjunct Professor, Dalhousie University, Department of Bioethics
Cystic Fibrosis Canada
• Kelly Grover, Chief Executive Officer
Innovative Medicines Canada
• Pamela Fralick, President
• Declan Hamill, Vice-President, Legal, Regulatory Affairs and Compliance
Institute of Health Economics
• Christopher McCabe, Chief Executive Officer and Executive Director
Liv-A-Little Foundation
• Erin Little, President
Pursuant to Standing Order 108(2) and the motion adopted by the committee on Monday, October 26, 2020, the committee resumed its study of the Patented Medicine Prices Review Board’s guidelines.

Steven Morgan, Anie Perrault, Sharon Batt, Jennifer Beeman and Kelly Grover made statements and, with Paul Levesque, answered questions.

At 2:44 p.m., the sitting was suspended.

At 2:45 p.m., the sitting resumed.

Pamela Fralick, Christopher McCabe and Erin Little made statements and, with Declan Hamill, answered questions.


Jennifer O'Connell moved, — That the Standing Committee on Health hold an additional meeting on the Patented Medicine Prices Review Board guidelines, as we were initially scheduled to do, in place of one of the meetings to be scheduled during the regularly scheduled meeting slots prior to the end of day on June 21, 2021; that the clerk invite the PMPRB to appear as a witness; that the meeting take place for two hours; and that, in addition to the PMPRB witness, each party be allowed to invite one witness for this meeting on the Patented Medicine Prices Review Board's guidelines.

Debate arose thereon.

The question was put on the motion and it was negatived on the following recorded division:

YEAS: Mike Kelloway, Jennifer O'Connell, Marcus Powlowski, Sonia Sidhu, Tony Van Bynen — 5;

NAYS: Don Davies, Chris d'Entremont, Ted Falk, Larry Maguire, Michelle Rempel Garner, Luc Thériault — 6.

At 4:12 p.m., the committee adjourned to the call of the Chair.

Jean-François Pagé
Clerk of the Committee